Emerging therapeutic targets in non-small cell lung cancer

Grace K. Dy; Alex A. Adjei

doi:10.1513/pats.200808-099LC

Emerging therapeutic targets in non-small cell lung cancer

Grace K. Dy, Alex A. Adjei

Medical Oncology

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

Over the last decade, systemic cancer therapies have evolved to exploit the growing knowledge of molecular aberrations involved in the development and progression of lung cancer. This review highlights the biological targets relevant in the treatment of non-small cell lung cancer.

Original language	English (US)
Pages (from-to)	218-223
Number of pages	6
Journal	Proceedings of the American Thoracic Society
Volume	6
Issue number	2
DOIs	https://doi.org/10.1513/pats.200808-099LC
State	Published - Apr 15 2009

Keywords

Angiogenesis
Epidermal growth factor receptor
Non-small cell lung cancer
Vaccine

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1513/pats.200808-099LC

Cite this

@article{62bd8207981947b4959fdbf88af1f7c9,

title = "Emerging therapeutic targets in non-small cell lung cancer",

abstract = "Over the last decade, systemic cancer therapies have evolved to exploit the growing knowledge of molecular aberrations involved in the development and progression of lung cancer. This review highlights the biological targets relevant in the treatment of non-small cell lung cancer.",

keywords = "Angiogenesis, Epidermal growth factor receptor, Non-small cell lung cancer, Vaccine",

author = "Dy, {Grace K.} and Adjei, {Alex A.}",

year = "2009",

month = apr,

day = "15",

doi = "10.1513/pats.200808-099LC",

language = "English (US)",

volume = "6",

pages = "218--223",

journal = "Proceedings of the American Thoracic Society",

issn = "1546-3222",

publisher = "American Thoracic Society",

number = "2",

}

TY - JOUR

T1 - Emerging therapeutic targets in non-small cell lung cancer

AU - Dy, Grace K.

AU - Adjei, Alex A.

PY - 2009/4/15

Y1 - 2009/4/15

N2 - Over the last decade, systemic cancer therapies have evolved to exploit the growing knowledge of molecular aberrations involved in the development and progression of lung cancer. This review highlights the biological targets relevant in the treatment of non-small cell lung cancer.

AB - Over the last decade, systemic cancer therapies have evolved to exploit the growing knowledge of molecular aberrations involved in the development and progression of lung cancer. This review highlights the biological targets relevant in the treatment of non-small cell lung cancer.

KW - Angiogenesis

KW - Epidermal growth factor receptor

KW - Non-small cell lung cancer

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=65349149344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349149344&partnerID=8YFLogxK

U2 - 10.1513/pats.200808-099LC

DO - 10.1513/pats.200808-099LC

M3 - Article

C2 - 19349491

AN - SCOPUS:65349149344

SN - 1546-3222

VL - 6

SP - 218

EP - 223

JO - Proceedings of the American Thoracic Society

JF - Proceedings of the American Thoracic Society

IS - 2

ER -

Emerging therapeutic targets in non-small cell lung cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this